Jeremy Goc

7PUBLICATIONS
45CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2024
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.

Anees Ahmed, Ann M Joseph, Jordan Zhou

|Oct 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium.

Christopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia

|Dec 24, 2022
Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC.

Priyanka Devi-Marulkar, Solène Fastenackels, Pierre Karapentiantz

|Sep 27, 2022
Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers.

Jeremy Goc, Gregory F Sonnenberg

|Sep 07, 2022
ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut.

Mengze Lyu, Hiroaki Suzuki, Lan Kang

|Oct 06, 2019
A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut.

Fei Teng, Jeremy Goc, Lei Zhou

Pageof 2

Frequent Collaborators

4 joint publications

Gregory F Sonnenberg

2 joint publications

Gérard Eberl

2 joint publications

Mengze Lyu

2 joint publications

Jordan Zhou